GettyImages-609179959-hero

Cardiovascular Medicine

Coronary Disease Clinical Trials

Myocardial Ischemia and Transfusion (MINT)

View Myocardial Ischemia and Transfusion (MINT) information

The purpose of this study is to assess among patients with an acute myocardial infarction and a hemoglobin concentration less than 10 g/dL, if a liberal transfusion strategy with a threshold of 10 g/dL reduces the rate of the composite outcome of all-cause mortality or recurrent nonfatal acute myocardial infarction through 30 days following randomization compared to a restrictive transfusion strategy with a threshold of 7 to 8 g/dL.

Primary Investigator: Michael Gitter, MD
Subinvestigators: Matthew Karafin, MD; Nicole Lohr, MD, PhD; David S. Marks, MD, MBA

Status: Currently enrolling
Sub Category: General Cardiology

Meet Our Team

headshot

Michael J. Gitter, MD, FACC

Associate Professor

headshot

Matthew Karafin, MD, MS

Associate Professor

headshot

Nicole Lohr, MD, PhD, FACC

Associate Professor, Medical Director Cardiovascular Clinical Trials

headshot

David S. Marks, MD, MBA

Director of Cardiovascular Clinical Trials

Cardiovascular Clinical Trials

The Cardiovascular Research Service is currently conducting drug and/or device trials in the cardiac subspecialties listed. However, this does not limit what we may be working on tomorrow.

Please contact the Cardiovascular Trials program by calling (414) 955-7021 or at DOMCVClinTriStaff@mcw.edu.